Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Animal Referral Medical Center Co's earnings before interest and taxes (EBIT) for the
six
months ended in Mar. 2026 was 円571 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,178 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Japan Animal Referral Medical Center Co's annualizedROC % for the quarter that ended in Mar. 2026 was 8.17%.
Japan Animal Referral Medical Center Co's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 15.47%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Japan Animal Referral Medical Center Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.73%.
Japan Animal Referral Medical Center Co (TSE:6039) EBIT Explanation
1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Japan Animal Referral Medical Center Co's annualizedROC % for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Animal Referral Medical Center Co EBIT Related Terms
Japan Animal Referral Medical Center Co EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Animal Referral Medical Center Co EBIT Chart
Japan Animal Referral Medical Center Co Annual Data
For the Personal Services subindustry, Japan Animal Referral Medical Center Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Animal Referral Medical Center Co EV-to-EBIT vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Japan Animal Referral Medical Center Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Japan Animal Referral Medical Center Co's EV-to-EBIT falls into.
Japan Animal Referral Medical Center Co EBIT Calculation
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円1,178 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Animal Referral Medical Center Co (TSE:6039) has a EBIT of 円1,178 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Japan Animal Referral Medical Center Co.
Is Japan Animal Referral Medical Center Co's EBIT too high?
Japan Animal Referral Medical Center Co's current EBIT is 円1,178 Mil. Overall, Japan Animal Referral Medical Center Co has a GF Score™ of 83/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Japan Animal Referral Medical Center Co's EBIT compare to ROL and SCI?
Japan Animal Referral Medical Center Co's EBIT of 円1,178 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Personal Services company?
A good EBIT depends on the Personal Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Japan Animal Referral Medical Center Co. Japan Animal Referral Medical Center Co's current EBIT is 円1,178 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Animal Referral Medical Center Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Animal Referral Medical Center Co (TSE:6039) is currently considered Significantly Overvalued. The stock's GF Value™ is 円641.17, compared to a current price of 円1,078.00 — trading 68.1% above its estimated fair value. The current EBIT is 円1,178 Mil. Japan Animal Referral Medical Center Co's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Japan Animal Referral Medical Center Co (TSE:6039), the current EBIT is 円1,178 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Animal Referral Medical Center Co (TSE:6039) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Animal Referral Medical Center Co stock appears to be overvalued.
The current stock price of 円1,078.00 is trading 68.1% above its estimated GF Value™ of 円641.17.
GuruFocus considers Japan Animal Referral Medical Center Co to be Significantly Overvalued.
Key valuation signals for TSE:6039:
EBIT: 円1,178 Mil
GF Value™: 円641.17 vs. price of 円1,078.00 (68.1% above fair value)
No single metric tells the full story. See the TSE:6039 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Animal Referral Medical Center Co Business Description
Japan Animal Referral Medical Center Co Ltd provides advanced clinical treatments for animals, contract clinical research in animal health and veterinarian education.
83GF Score
Get the complete analysis for TSE:6039
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6039 has been successfully added to your 
